Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma
NCT02825147Phase 2Completed
- Sponsor
- Ruijin Hospital
- Start
- Sep 2013
- Primary completion
- Mar 2016
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Ruijin Hospital. Started Sep 2013; status: completed.
02
Drugs
pegaspargase
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT02825147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825147.